OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology of negative symptom dimensions of schizophrenia – Current developments and implications for treatment
Indrit Bègue, Stefan Kaiser, Matthias Kirschner
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 74-88
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments
Stephen R. Marder, Daniel Umbricht
Schizophrenia Research (2023) Vol. 258, pp. 71-77
Open Access | Times Cited: 44

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study
Manuel Canal‐Rivero, Miguel Ruiz‐Veguilla, Víctor Ortiz‐García de la Foz, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 309-318
Open Access | Times Cited: 18

Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia
Qiongqiong Wu, Xiaoyi Wang, Ying Wang, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 11, pp. 1609-1624
Open Access | Times Cited: 41

The Important Role of Motivation and Pleasure Deficits on Social Functioning in Patients With Schizophrenia: A Network Analysis
Hui‐xin Hu, Wilson Y S Lau, P Y Eugenia, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 4, pp. 860-870
Open Access | Times Cited: 28

Theories and models of negative symptoms in schizophrenia and clinical implications
Raymond C. K. Chan, Lingling Wang, Simon S. Y. Lui
Nature Reviews Psychology (2022) Vol. 1, Iss. 8, pp. 454-467
Closed Access | Times Cited: 24

Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial
Jacopo Lisoni, Gabriele Nibbio, Giulia Baldacci, et al.
Journal of Affective Disorders (2024) Vol. 349, pp. 165-175
Closed Access | Times Cited: 5

16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms
Yihuan Chen, Huan Yu, Fen Xue, et al.
Brain and Behavior (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 5

A Narrative Review of Speech and EEG Features for Schizophrenia Detection: Progress and Challenges
Felipe Teixeira, Miguel Rocha e Costa, José Pio Abreu, et al.
Bioengineering (2023) Vol. 10, Iss. 4, pp. 493-493
Open Access | Times Cited: 12

Time is the enemy: Negative symptoms are related to even slight differences in the duration of untreated psychosis
Andrea Slováková, Jan Kúdelka, Antonín Škoch, et al.
Comprehensive Psychiatry (2024) Vol. 130, pp. 152450-152450
Open Access | Times Cited: 4

Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studies
Michel Sabé, Nan Zhao, Stefan Kaiser
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 415-425
Open Access | Times Cited: 32

Schizophrenia: Antipsychotics and drug development
Gary Remington, Margaret Hahn, Sri Mahavir Agarwal, et al.
Behavioural Brain Research (2021) Vol. 414, pp. 113507-113507
Closed Access | Times Cited: 25

Neurobiological fingerprints of negative symptoms in schizophrenia identified by connectome‐based modeling
Ziyang Gao, Yuan Xiao, Fei Zhu, et al.
Psychiatry and Clinical Neurosciences (2025)
Closed Access

Reduced temporal variability of cortical excitation/inhibition ratio in schizophrenia
Frigyes Sámuel Rácz, Kinga Farkas, Melinda Becske, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access

Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials
Lorenzo Moccia, Francesca Bardi, Maria Benedetta Anesini, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 540-540
Open Access

Multi-feature fusion RFE random forest for schizophrenia classification and treatment response prediction
Chang Wang, Rui Zhang, Jiyuan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

External stress, formaldehyde, and schizophrenia: a new mouse model for mental illness research
Jun-Hao Cheng, Zihui Sun, Hao Zhang, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access

Association of core brain networks with antipsychotic therapeutic effects in first-episode schizophrenia
Yuling Luo, Tianyuan Zhu, Yu Zhang, et al.
Cerebral Cortex (2025) Vol. 35, Iss. 4
Closed Access

Fronto-occipital dyscommunication associates with brain hierarchy in schizophrenia
Haonan Pei, Hechun Li, Changyue Hou, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access

Negative symptomatology and clozapine-induced obsessive–compulsive symptoms: a cross-sectional analysis
Phillip Kleymann, Carla Morgenroth, Stefan Gutwinski, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Open Access

Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum
Matthias Kirschner, André Schmidt, Benazir Hodzic-Santor, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 3, pp. 849-863
Open Access | Times Cited: 27

Page 1 - Next Page

Scroll to top